Daniel Martín-Pérez

1.7k citations
14 papers · 1.1k indexed · h-index 11
Topics
Hematopoietic Stem Cell Transplantation (4 papers)Acute Myeloid Leukemia Research (2 papers)T-cell and Retrovirus Studies (2 papers)

In The Last Decade

Daniel Martín-Pérez

13 papers receiving 1.1k citations

Peers

Daniel Martín-Pérez
Comparison fields: 5 of 76
  • Hematology 474
  • Molecular Biology 440
  • Genetics 402
  • Immunology 242
  • Oncology 173
Replace Maher Hanoun with:
Maher Hanoun Germany
Nathalie Brouard France
Lara Rossi Italy
Kfir Lapid Israel
Viktor Janzen Germany
Halley Pierce United States
Karin Golan Israel
Tomer Itkin Israel
Nayoun Kim South Korea
Shiri Gur‐Cohen Israel
Daniel Martín-Pérez relative to Maher Hanoun Germany Maher Hanoun's profile →
Citations per field
00.5×1.5×
Maher Hanoun · 1×
Citations per year

Countries citing papers authored by Daniel Martín-Pérez

Since Specialization
Citations

This map shows the geographic impact of Daniel Martín-Pérez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Martín-Pérez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Martín-Pérez more than expected).

Fields of papers citing papers by Daniel Martín-Pérez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Martín-Pérez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Martín-Pérez. The network helps show where Daniel Martín-Pérez may publish in the future.

Co-authorship network of co-authors of Daniel Martín-Pérez

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Martín-Pérez. A scholar is included among the top collaborators of Daniel Martín-Pérez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Martín-Pérez. Daniel Martín-Pérez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 0
2 11
3 74
4 3
5 91
6 324
7 233
8 114
9 39
10 86
11 52
12 35
13 1
14 17

About Daniel Martín-Pérez

Daniel Martín-Pérez is a scholar working on Hematology, Genetics and Orthopedics and Sports Medicine, having authored 14 papers that have together received 1.1k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (4 papers), Acute Myeloid Leukemia Research (2 papers) and T-cell and Retrovirus Studies (2 papers). The work is most often cited by research in Hematology (474 citations), Genetics (402 citations) and Immunology (242 citations). Daniel Martín-Pérez has collaborated with scholars based in Spain, United States and Switzerland. Frequent co-authors include Simón Méndez‐Ferrer, Joan Isern, Lorena Arranz, Andrés García‐García, Abel Sánchez‐Aguilera, A. MARTIN, Miguel Á. Piris, Radek C. Skoda, Jürg Schwaller and Xavier Langa. Their work appears in journals such as Nature, Nature Communications and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026